Flotufolastat F-18 Gallium trials for Prostate cancer

All Flotufolastat F-18 Gallium trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Flotufolastat F-18 Gallium for Prostate cancer

• Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
  NCT06389786 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 85 Years · Sex: Male · 1 location
• An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
  NCT06865768 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
  NCT06813898 · Phase: Early Phase 1 · Ages: No age limits stated · Sex: Male · 1 location
• Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
  NCT07025369 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
  NCT07164027 · Phase: Early Phase 1 · Ages: 18 Years to 90 Years · Sex: Male · 1 location
• rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
  NCT05852041 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Flotufolastat F-18 Gallium for Prostate cancer?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.